92 related articles for article (PubMed ID: 24519884)
1. Antioxidant SkQ1 delays sarcopenia-associated damage of mitochondrial ultrastructure.
Vays VB; Eldarov CM; Vangely IM; Kolosova NG; Bakeeva LE; Skulachev VP
Aging (Albany NY); 2014 Feb; 6(2):140-8. PubMed ID: 24519884
[TBL] [Abstract][Full Text] [Related]
2. Retinoprotective Effect of SkQ1, Visomitin Eye Drops, Is Associated with Suppression of P38 MAPK and ERK1/2 Signaling Pathways Activity.
Muraleva NA; Zhdankina AA; Fursova AZ; Kolosova NG
Biochemistry (Mosc); 2024 Feb; 89(2):201-211. PubMed ID: 38622090
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Mitochondrial Antioxidant Plastoquinonyl-decyl-triphenylphosphonium Bromide (SkQ1) in the Rat Model of Autoimmune Arthritis.
Andreev-Andrievskiy AA; Kolosova NG; Stefanova NA; Lovat MV; Egorov MV; Manskikh VN; Zinovkin RA; Galkin II; Prikhodko AS; Skulachev MV; Lukashev AN
Oxid Med Cell Longev; 2016; 2016():8703645. PubMed ID: 27293517
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria-Targeted Antioxidant SkQ1 Prevents Anesthesia-Induced Dry Eye Syndrome.
Zernii EY; Gancharova OS; Baksheeva VE; Golovastova MO; Kabanova EI; Savchenko MS; Tiulina VV; Sotnikova LF; Zamyatnin AA; Philippov PP; Senin II
Oxid Med Cell Longev; 2017; 2017():9281519. PubMed ID: 29158874
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Effect of the Mitochondria-Targeted Antioxidant SkQ1 on the Culture Model of Multiple Sclerosis.
Fetisova EK; Muntyan MS; Lyamzaev KG; Chernyak BV
Oxid Med Cell Longev; 2019; 2019():2082561. PubMed ID: 31354902
[TBL] [Abstract][Full Text] [Related]
6. Age-associated murine cardiac lesions are attenuated by the mitochondria-targeted antioxidant SkQ1.
Manskikh VN; Gancharova OS; Nikiforova AI; Krasilshchikova MS; Shabalina IG; Egorov MV; Karger EM; Milanovsky GE; Galkin II; Skulachev VP; Zinovkin RA
Histol Histopathol; 2015 Mar; 30(3):353-60. PubMed ID: 25323729
[TBL] [Abstract][Full Text] [Related]
7. Advances in development of rechargeable mitochondrial antioxidants.
Lukashev AN; Skulachev MV; Ostapenko V; Savchenko AY; Pavshintsev VV; Skulachev VP
Prog Mol Biol Transl Sci; 2014; 127():251-65. PubMed ID: 25149221
[TBL] [Abstract][Full Text] [Related]
8. The mitochondria-targeted antioxidant SkQ1 restores αB-crystallin expression and protects against AMD-like retinopathy in OXYS rats.
Muraleva NA; Kozhevnikova OS; Zhdankina AA; Stefanova NA; Karamysheva TV; Fursova AZ; Kolosova NG
Cell Cycle; 2014; 13(22):3499-505. PubMed ID: 25483086
[TBL] [Abstract][Full Text] [Related]
9. Role of mitochondrial reactive oxygen species in age-related inflammatory activation of endothelium.
Zinovkin RA; Romaschenko VP; Galkin II; Zakharova VV; Pletjushkina OY; Chernyak BV; Popova EN
Aging (Albany NY); 2014 Aug; 6(8):661-74. PubMed ID: 25239871
[TBL] [Abstract][Full Text] [Related]
10. The Mitochondria-Targeted Antioxidant SkQ1 Downregulates Aryl Hydrocarbon Receptor-Dependent Genes in the Retina of OXYS Rats with AMD-Like Retinopathy.
Perepechaeva ML; Grishanova AY; Rudnitskaya EA; Kolosova NG
J Ophthalmol; 2014; 2014():530943. PubMed ID: 25132985
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial oxidative stress in aging and healthspan.
Dai DF; Chiao YA; Marcinek DJ; Szeto HH; Rabinovitch PS
Longev Healthspan; 2014; 3():6. PubMed ID: 24860647
[TBL] [Abstract][Full Text] [Related]
12. The Role of SKQ1 (Visomitin) in Inflammation and Wound Healing of the Ocular Surface.
Wei Y; Troger A; Spahiu V; Perekhvatova N; Skulachev M; Petrov A; Chernyak B; Asbell P
Ophthalmol Ther; 2019 Mar; 8(1):63-73. PubMed ID: 30565203
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria-targeted antioxidant SkQ1 suppresses fibrosarcoma and rhabdomyosarcoma tumour cell growth.
Titova E; Shagieva G; Ivanova O; Domnina L; Domninskaya M; Strelkova O; Khromova N; Kopnin P; Chernyak B; Skulachev V; Dugina V
Cell Cycle; 2018; 17(14):1797-1811. PubMed ID: 29995559
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria-targeted antioxidant SkQ1 improves impaired dermal wound healing in old mice.
Demyanenko IA; Popova EN; Zakharova VV; Ilyinskaya OP; Vasilieva TV; Romashchenko VP; Fedorov AV; Manskikh VN; Skulachev MV; Zinovkin RA; Pletjushkina OY; Skulachev VP; Chernyak BV
Aging (Albany NY); 2015 Jul; 7(7):475-85. PubMed ID: 26187706
[TBL] [Abstract][Full Text] [Related]
15. Supplementation of SkQ1 Increases Mouse In Vitro Oocyte Maturation and Subsequent Embryonic Development by Reducing Oxidative Stress.
Li Z; Zhang Y; Cao J; Xing X; Liang Y; Zhang Y; Tang X; Lin S; Wu Z; Li Z; Huang S
Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675415
[TBL] [Abstract][Full Text] [Related]
16. Suppression of Age-Related Macular Degeneration-like Pathology by c-Jun N-Terminal Kinase Inhibitor IQ-1S.
Zhdankina AA; Tikhonov DI; Logvinov SV; Plotnikov MB; Khlebnikov AI; Kolosova NG
Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830932
[TBL] [Abstract][Full Text] [Related]
17. From the Bench to the Bedside: Branched Amino Acid and Micronutrient Strategies to Improve Mitochondrial Dysfunction Leading to Sarcopenia.
Romani M; Berger MM; D'Amelio P
Nutrients; 2022 Jan; 14(3):. PubMed ID: 35276842
[TBL] [Abstract][Full Text] [Related]
18. Progressive reorganization of mitochondrial apparatus in aging skeletal muscle of naked mole rats (
Vays V; Vangely I; Eldarov C; Holtze S; Hildebrandt T; Bakeeva L; Skulachev V
Aging (Albany NY); 2021 Nov; 13(22):24524-24541. PubMed ID: 34839281
[TBL] [Abstract][Full Text] [Related]
19. Sulforaphane prevents age-associated cardiac and muscular dysfunction through Nrf2 signaling.
Bose C; Alves I; Singh P; Palade PT; Carvalho E; Børsheim E; Jun SR; Cheema A; Boerma M; Awasthi S; Singh SP
Aging Cell; 2020 Nov; 19(11):e13261. PubMed ID: 33067900
[TBL] [Abstract][Full Text] [Related]
20. Neutralizing mitochondrial ROS does not rescue muscle atrophy induced by hindlimb unloading in female mice.
Eshima H; Siripoksup P; Mahmassani ZS; Johnson JM; Ferrara PJ; Verkerke ARP; Salcedo A; Drummond MJ; Funai K
J Appl Physiol (1985); 2020 Jul; 129(1):124-132. PubMed ID: 32552434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
